The Global Market for Anti-Adhesion Products is Projected to Reach US$2.7 Billion by 2022

Focus on Adhesion Reduction Management Drives Demand for Anti-Adhesion Products, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Anti-Adhesion Products market. The global market for Anti-Adhesion Products is projected to reach US$2.7 billion by 2022 driven by the focus on reducing the direct healthcare costs associated with admissions and treatment of adhesion-related complications and poorer patient outcome and clinical ramifications of postsurgical adhesive diseases.

In the healthcare sector, the term ‘adhesion’ denotes sticky fibrous band of scar tissue typically formed between organs and tissues when they adhere to each other following a surgery or any non-surgical trauma. While adhesions may occur due to non-surgical trauma such as blunt force, infection, endometriosis, chemotherapy, radiation or cancer, they are however most commonly caused due to surgery. Over 85% of adhesion cases are a result of post-surgical complications. Adhesion formation has and still continues to remain the most common post-surgical complication with huge unmet market needs. Adhesion formation after a surgery is a part of natural healing response to tissue trauma and a normal step in a body’s post-surgery healing process. However, when they connect wrong or unrelated tissues with each other, adhesions can lead to serious clinical implications such as intestinal blockage, pelvic pain, sensation loss and infertility depending on their size and location.

The ever-present risk of adhesions associated with surgical procedures is generating demand for efficient solutions to tackle the problem. Research studies have revealed that numerous undesirable complications can be avoided if the development of adhesion is successfully prevented within 3-5 days post-surgery when tissue healing and regrowth begins. Demand is therefore especially high for advanced adhesion barriers capable of fully preventing the formation of adhesions. The growth in the market is led by factors such as demographic trends, number of surgical procedures, and growing awareness among patients and physicians alike on the medical implications of adhesions. With over 250 million surgical procedures being performed annually across the globe, the number of patients exposed to the risk of post-surgical adhesion formation is extremely high, thereby creating significant demand for anti-adhesion products. Given that abdominal, gynaecological/pelvic and cardio-thoracic surgical procedures are followed by post-surgical adhesion formation, the market stands to benefit from the growing incidence of cardiovascular diseases and increase in reconstructive pelvic surgery among the aging women population.

As stated by the new market research report on Anti-Adhesion Products, the United States represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market with a CAGR of 12.7% over the analysis period. The growth in the region is led by developing healthcare infrastructure, rising affluence and increase in per capita healthcare spending, increased ability to afford surgical interventional care, and rise in the number of surgeries performed as a result of the growing trend of medical tourism. General/abdominal surgery represents the largest application area accounting for a lion’s share in the market in the year 2015. Pelvic/gynecological surgery is forecast to emerge as the fastest growing end-use market growing at a projected CAGR of 9.2% over the analysis period.

Major players covered in the report include Anika Therapeutics Inc., Baxter Healthcare Ltd., Ethicon Inc., FzioMed Inc., Integra LifeSciences Corporation, Magen OrthoMed Ltd., MAST Biosurgery AG, and Sanofi SA, among others.

The research report titled “Anti-Adhesion Products: A Global Strategic Business Report”, announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, issues, drivers,  mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections for all major geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin-America (Brazil and Rest of Latin America) and Rest of World. The global and regional markets are also analyzed by applications areas, such as General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Others (Include Cardiothoracic Surgery, ENT, and Spine/Neurology Surgery).

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.